Role of Lipids in Spheroidal High Density Lipoproteins

PLoS Computational Biology

Volumn 6, Issue 10, 2010, Pages

  Vuorela, Timo ^a   Catte, Andrea ^a,b   Niemelä, Perttu S ^c   Hall, Anette ^a   Hyvönen, Marja T ^d   Marrink, Siewert Jan ^e   Karttunen, Mikko ^f   Vattulainen, Ilpo ^a,g,h  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b University of Alabama at Birmingham   (United States)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g AALTO UNIVERSITY   (Finland)

^h UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COARSE-GRAINED MODELING; CONFORMATIONS; DROPS; DRUG DELIVERY; ENTROPY; HYDROPHOBICITY; LIPID BILAYERS; LIPOPROTEINS; MOLECULAR DYNAMICS; MOLECULES; SELF ASSEMBLY;

APOLIPOPROTEIN A-I; COARSE-GRAINED; COMPUTATIONAL STUDIES; DYNAMICS SIMULATION; HIGH DENSITY LIPOPROTEIN; LIPID DROPLETS; LIPID-PROTEIN INTERACTIONS; LIPOPROTEIN PARTICLES; PROPERTY; STRUCTURE AND DYNAMICS;

CHOLESTEROL;

APOLIPOPROTEIN A1; CHOLESTEROL; FAT DROPLET; HIGH DENSITY LIPOPROTEIN; LIPID; CHOLESTEROL ESTER; PHOSPHOLIPID; TRIACYLGLYCEROL;

ARTICLE; CHEMICAL STRUCTURE; CHOLESTEROL TRANSPORT; HYDROPHOBICITY; LIPID ANALYSIS; LIPID COMPOSITION; LIPOGENESIS; MOLECULAR DYNAMICS; MOLECULAR MODEL; PROTEIN LIPID INTERACTION; STRUCTURE ANALYSIS; BIOLOGY; CHEMICAL PHENOMENA; CHEMISTRY; COMPUTER SIMULATION; HUMAN; LIPID METABOLISM; METABOLISM; NUCLEAR MAGNETIC RESONANCE; REPRODUCIBILITY; THERMODYNAMICS;

APOLIPOPROTEIN A-I; CHOLESTEROL; CHOLESTEROL ESTERS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPID METABOLISM; LIPIDS; LIPOPROTEINS, HDL; MOLECULAR DYNAMICS SIMULATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHOLIPIDS; REPRODUCIBILITY OF RESULTS; THERMODYNAMICS; TRIGLYCERIDES;

EID: 78349243645     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1000964     Document Type: Article

References (79)

1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death in the United States, 2000. JAMA 291: 1238-1245.
2. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, et al. (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256: 2835-2838.
3. Hevonoja T, Pentikäinen MO, Hyvönen MT, Kovanen PT, Ala-Korpela M (2000) Structure of low density lipoprotein (LDL) particles: Basis for understanding molecular changes in modified LDL. Biochim Biophys Acta 1488: 189-210.
4. Colvin PL, Parks JS (1999) Metabolism of high density lipoprotein subfractions. Curr Opin Lipidol 10: 309-314.
5. Linsel-Nitschke P, Tall AR (2005) HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov 4: 193-205.
6. Lund-Katz S, Liu L, Thuahnai ST, Phillips MC (2003) High density lipoprotein structure. Front Biosci 8: d1044-1054.
7. Jackson RL, Morrisett JD, Gotto AM (1976) Lipoprotein structure and metabolism. Physiol Rev 56: 259-316.
8. von Eckardstein A, Nofer JR, Assmann G (2001) High density lipoproteins and arteriosclerosis - role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 21: 13-27.
9. Oram JF, Heinecke JW (2005) ATP-binding cassette transporter A1: A cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 85: 1343-1372.
10. Jonas A (2000) Lecithin cholesterol acyltransferase. Biochim Biophys Acta 1529: 245-256.
11. Peelman F, Vinaimont N, Verhee A, Vanloo B, Verschelde JL, et al. (1998) A proposed architecture for lecithin cholesterol acyl transferase (LCAT): Identification of the catalytic triad and molecular modeling. Protein Sci 7: 587-599.
12. Rogers DP, Roberts LM, Lebowitz J, Datta G, Anantharamaiah GM, et al. (1998) The lipid-free structure of apolipoprotein A-I: Effects of amino-terminal deletions. Biochemistry 37: 11714-11725.
13. Brouillette CG, Anantharamaiah GM, Engler JA, Borhani DW (2001) Structural models of human apolipoprotein A-I: A critical analysis and review. Biochim Biophys Acta 1531: 4-46.
14. Silva RA, Hilliard GM, Fang J, Macha S, Davidson WS (2005) A threedimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading. Biochemistry 44: 2759-2769.
15. Ajees AA, Anantharamaiah GM, Mishra VK, Hussain MM, Murthy HMK (2006) Crystal structure of human apolipoprotein A-I: Insights into its protective effect against cardiovascular diseases. Proc Natl Acad Sci USA 103: 2126-2131.
16. Davidson WS, Silva RA (2005) Apolipoprotein structural organization in high density lipoproteins: Belts, bundles, hinges and hairpins. Curr Opin Lipidol 16: 295-300.
17. Saito H, Dhanasekaran P, Nguyen D, Deridder E, Holvoet P, et al. (2004) Alpha-helix formation is required for high affinity binding of human apolipoprotein A-I to lipids. J Biol Chem 279: 20974-20981.
18. Gangani D, Silva RA, Huang R, Morris J, Fang J, Gracheva EO, et al. (2008) Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc Natl Acad Sci USA 105: 12176-12181.
19. Maldonado EN, Romero JR, Ochoa B, Avelda MI (2001) Lipid and fatty acid composition of canine lipoproteins. Comp Biochem Physiol B, Biochem Mol Biol 128: 719-729.
20. Kotronen A, Velagapudi VR, Yetukuri L, Westerbacka J, Bergholm R, et al. (2009) Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia 52: 684-690.
21. Edelstein C, Kezdy FJ, Scanu AM, Shen BW (1979) Apolipoproteins and the structural organization of plasma lipoproteins: Human plasma high density lipoprotein-3. J Lipid Res 20: 143-153.
22. Cushley RJ, Okon M (2002) NMR studies of lipoprotein structure. Annu Rev Biophys Biomol Struct 31: 177-206.
23. Mishra VK, Palgunachari MN, Segrest JP, Anantharamaiah GM (1994) Interactions of synthetic peptide analogs of the class A amphipathic helix with lipids. Evidence for the snorkel hypothesis. J Biol Chem 269: 7185-7191.
24. Segrest JP, Garber DW, Brouillette CG, Harvey SC, Anantharamaiah GM (1994) The amphipathic alpha helix: A multifunctional structural motif in plasma apolipoproteins. Adv Protein Chem 45: 303-369.
25. Palgunachari MN, Mishra VK, Lund-Katz S, Phillips MC, Adeyeye SO, et al. (1996) Only the two end helixes of eight tandem amphipathic helical domains of human apoA-I have significant lipid affinity. Implications for HDL assembly. Arterioscler Thromb Vasc Biol 16: 328-338.
26. Mishra VK, Palgunachari MN, Datta G, Phillips MC, Lund-Katz S, et al. (1998) Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic a-helixes. Biochemistry 37: 10313-10324.
27. Anantharamaiah GM, Mishra VK, Garber DW, Datta G, Handattu SP, et al. (2007) Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides. J Lipid Res 48: 1915-1923.
28. Hite RK, Raunser S, Walz T (2007) Revival of electron crystallography. Curr Opin Struct Biol 17: 389-395.
29. Shih AY, Denisov IG, Phillips JC, Sligar SG, Schulten K (2005) Molecular dynamics simulations of discoidal bilayers assembled from truncated human lipoproteins. Biophys J 88: 548-556.
30. Catte A, Patterson JC, Jones MK, Jerome WG, Bashtovyy D, et al. (2006) Novel changes in discoidal high density lipoprotein morphology: A molecular dynamics study. Biophys J 90: 4345-4360.
31. Shih AY, Arkhipov A, Freddolino PL, Schulten K (2006) Coarse grained protein-lipid model with application to lipoprotein particles. J Phys Chem B 110: 3674-3684.
32. Shih AY, Arkhipov A, Freddolino PL, Sligar SG, Schulten K (2007) Assembly of lipids and proteins into lipoprotein particles. J Phys Chem B 111: 11095-11104.
33. Heikelä M, Vattulainen I, Hyvönen MT (2006) Atomistic simulation studies of cholesteryl oleates: Model for the core of lipoprotein particles. Biophys J 90: 2247-2257.
34. Hall A, Repakova J, Vattulainen I (2008) Modelling of the triglyceride rich core in lipid droplets. J Phys Chem B 112: 13772-13782.
35. Koivuniemi A, Heikelä M, Kovanen PT, Vattulainen I, Hyvönen MT (2009) Atomistic simulations of phosphatidylcholines and cholesteryl esters in highdensity lipoprotein-sized lipid droplet and trilayer: Clues to cholesteryl ester transport and storage. Biophys J 96: 4099-4108.
36. Catte A, Patterson JC, Bashtovyy D, Jones MK, Gu F, et al. (2008) Structure of spheroidal HDL particles revealed by combined atomistic and coarse grained simulations. Biophys J 94: 2306-2319.
37. Sparks DL, Lund-Katz S, Phillips MC (1992) The charge and structural stability of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. J Biol Chem 267: 25839-25847.
38. Shih AY, Sligar SG, Schulten K (2009) Maturation of high-density lipoproteins. J R Soc Interface 6: 863-871.
39. Marrink SJ, Risselada HJ, Yefimov S, Tieleman DP, de Vries AH (2007) The MARTINI force field: Coarse grained model for biomolecular simulations. J Phys Chem B 111: 7812-7824.
40. Monticelli L, Kandasamy S, Periole X, Larson R, Tieleman DP, et al. (2008) The MARTINI coarse grained force field: Extension to proteins. J Chem Theor Comp 4: 819-834.
41. Risselada HJ, Marrink SJ (2008) The molecular face of lipid rafts in model membranes. Proc Natl Acad Sci USA 105: 17367-17372.
42. Ollila OHS, Risselada HJ, Louhivuori M, Lindahl E, Vattulainen I, et al. (2009) 3D pressure field in lipid membranes and membrane-protein complexes. Phys Rev Lett 102: 078101.
43. Qiu X, Mistry A, Ammirati MJ, Chrunyk BA, Clark RW, et al. (2007) Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules. Nat Struct Mol Biol 14: 106-113.
44. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, et al. (2007) Nanocarriers as an emerging platform for cancer therapy. Nature Nanotech 2: 751-760.
45. Oda MN, Hargreaves PL, Beckstead JA, Redmond KA, van Antwerpen R, et al. (2006) Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B. J Lipid Res 47: 260-267.
46. Lou B, Liao XL, Wu MP, Cheng PF, Yin CY, et al. (2005) High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells. World J Gastroenterol 11: 954-959.
47. Frias JC, Williams KJ, Fisher EA, Fayad ZA (2004) Recombinant HDL-like nanoparticles: A specific contrast agent for MRI of atherosclerotic plaques. J Am Chem Soc 126: 16316-16317.
48. Frias JC, Ma Y, Williams KJ, Fayad ZA, Fisher EA (2006) Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano Lett 6: 2220-2224.
49. Kratzer I, Wernig K, Panzenboeck U, Bernhart E, Reicher H, et al. (2007) Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier. J Control Release 117: 301-311.
50. Briley-Saebo KC, Mulder WJM, Mani V, Hyafil F, Amirbekian V, et al. (2007) Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probes. J Magn Reson Imaging 26: 460-479.
51. Canet-Soulas E, Letourneur D (2007) Biomarkers of atherosclerosis and the potential of MRI for the diagnosis of vulnerable plaque. Magn Reson Mater Phys 20: 129-142.
52. Rukmini R, Rawat SS, Biswas SC, Chattopadhyay A (2001) Cholesterol organization in membranes at low concentrations: Effects of curvature stress and membrane thickness. Biophys J 81: 2122-2134.
53. Huang C, Mason JT (1978) Geometric packing constraints in egg phosphatidylcholine vesicles. Proc Natl Acad Sci USA 75: 308-310.
54. Lemmich J, Mortensen K, Ipsen JH, Honger T, Bauer R, et al. (1997) The effect of cholesterol in small amounts on lipid bilayer softness in the region of the main phase transition. Eur Biophys J 25: 293-304.
55. Harroun TA, Katsaras J, Wassall SR (2008) Cholesterol is found to reside in the center of a polyunsaturated lipid membrane. Biochemistry 47: 7090-7096.
56. Marrink SJ, de Vries A, Harroun TA, Katsaras J, Wassall SR (2008) Cholesterol shows preference for the interior of polyunsaturated lipid membranes. J Am Chem Soc 130: 10-11.
57. Lund-Katz S, Phillips MC (1986) Packing of cholesterol molecules in human low-density lipoprotein. Biochemistry 25: 1562-1568.
58. Filippov A, Orädd G, Lindblom G (2003) The effect of cholesterol on the lateral diffusion of phospholipids in oriented bilayers. Biophys J 84: 3079-3086.
59. Vauhkonen M, Sassaroli M, Somerharju P, Eisinger J (1989) Lateral diffusion of phospholipids in the lipid surface of human low-density lipoprotein measured with a pyrenyl phospholipid probe. Eur J Biochem 186: 465-471.
60. Massey JB, Pownall HJ (1998) Surface properties of native human plasma lipoproteins and lipoprotein models. Biophys J 74: 869-878.
61. Apajalahti T, Niemela P, Govindan PN, Miettinen MS, Salonen E, et al. (2010) Concerted diffusion of lipids in raft-like membranes. Faraday Disc 144: 411-430.
62. Thomas A, Meurisse R, Charloteaux B, Brasseur R (2002) Aromatic side-chain interactions in proteins. I. Main structural features. Proteins: Struct Func Gen 48: 628-634.
63. Wimley WC, White SH (1996) Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nature Struct Biol 3: 842-848.
64. Dergunov AD, Dobretsov GE, Visvikis S, Siest G (2001) Protein-lipid interactions in reconstituted high density lipoproteins: Apolipoprotein and cholesterol influence. Chem Phys Lipids 113: 67-82.
65. Lund-Katz S, Phillips MC (1984) Packing of cholesterol molecules in human high-density lipoproteins. Biochemistry 23: 1130-1138.
66. Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: A new therapeutic targest at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58: 342-374.
67. Yetukuri L, Soderlund S, Koivuniemi A, Seppanen-Laakso T, Niemela PS, et al. (2010) Composition and lipid spatial distribution of high density lipoprotein particles in subjects with low and high HDL-cholesterol. J Lipid Res 51: 2341-2351.
68. Segrest JP, Jones MK, Klon AE, Sheldahl CJ, Hellinger M, et al. (1999) A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J Biol Chem 274: 31755-31758.
69. Borhani DW, Rogers DP, Engler JA, Brouillette CG (1997) Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc Natl Acad Sci USA 94: 12291-12296.
70. Segrest JP, Harvey SC, Zannis V (2000) Detailed molecular model of apolipoprotein A-I on the surface of high-density lipoproteins and its functional implications. Trends Cardiovasc Med 10: 246-252.
71. Klon AE, Segrest JP, Harvey SC (2002) Comparative models for human apolipoprotein A-I bound to lipid in discoidal high-density lipoprotein particles. Biochemistry 41: 10895-10905.
72. Klon AE, Segrest JP, Harvey SC (2002) Molecular dynamics simulations on discoidal HDL particles suggest a mechanism for rotation in the apoA-I belt model. J Mol Biol 324: 703-721.
73. Okon M, Frank PG, Marcel YL, Cushley RJ (2002) Heteronuclear NMR studies of human serum apolipoprotein A-I part I. Secondary structure in lipid-mimetic solution. FEBS Lett 517: 139-143.
74. Lindahl E, Hess B, van der Spoel D (2001) GROMACS 3.0: A package for molecular simulation and trajectory analysis. J Mol Mod 7: 306-317.
75. Nosé S (1984) A molecular dynamics method for simulations in the canonical Ensemble. Mol Phys 52: 255-268.
76. Hoover WG (1985) Canonical dynamics: Equilibrium phase-space fistributions. Phys Rev 31: 1695-1697.
77. Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: A new molecular dynamics method. J Appl Phys 52: 7182-7190.
78. Niemela PS, Miettinen M, Monticelli L, Hammaren H, Bjelkmar P, et al. (2010) Membrane proteins diffuse as dynamic complexes with lipids. J Am Chem Soc 132: 7574-7575.
79. Ramadurai S, Holt A, Schafer LV, Krasnikov VV, Rijkers DTS, et al. (2010) Influence of hydrophobic mismatch and amino acid composition on the lateral diffusion of transmembrane peptides. Biophys J 99: 1447-1454.